Trump Administration Plans Autism Announcement Linking Pain Reliever, Vitamin Deficiency

President Donald Trump is set to make a significant announcement from the Oval Office regarding autism, previewing it as possibly one of his most important news conferences. The announcement is expected to link the use of the pain reliever Tylenol (acetaminophen) during pregnancy to an increased risk of autism in children, alongside low levels of folate, a vitamin crucial for fetal brain and spine development. The administration also plans to highlight folinic acid (leucovorin), a form of folate, as a potential treatment to reduce autism symptoms. Currently, Tylenol is considered safe for pregnant women, but health officials may warn against its use early in pregnancy unless necessary to treat fever. Tylenol's manufacturer, Kenvue, has engaged with health officials and emphasizes that acetaminophen remains the safest option for pain relief during pregnancy when needed. President Trump expressed confidence that the administration has found answers to autism and intends to prevent it going forward.